TY  - GEN
AU  - Awad,Mark M
AU  - Leonardi,Giulia C
AU  - Kravets,Sasha
AU  - Dahlberg,Suzanne E
AU  - Drilon,Alexander
AU  - Noonan,Sinead A
AU  - Camidge,D Ross
AU  - Ou,Sai-Hong I
AU  - Costa,Daniel B
AU  - Gadgeel,Shirish M
AU  - Steuer,Conor E
AU  - Forde,Patrick M
AU  - Zhu,Viola W
AU  - Fukuda,Yoko
AU  - Clark,Jeffrey W
AU  - Jänne,Pasi A
AU  - Mok,Tony
AU  - Sholl,Lynette M
AU  - Heist,Rebecca S
TI  - Impact of MET inhibitors on survival among patients with non-small cell lung cancer harboring MET exon 14 mutations: a retrospective analysis
SN  - 1872-8332
PY  - 2020///0305
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - Carcinoma, Non-Small-Cell Lung
KW  - drug therapy
KW  - Crizotinib
KW  - Exons
KW  - genetics
KW  - Female
KW  - High-Throughput Nucleotide Sequencing
KW  - Humans
KW  - Lung Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Mutation
KW  - Protein Kinase Inhibitors
KW  - Proto-Oncogene Proteins c-met
KW  - antagonists & inhibitors
KW  - Retrospective Studies
KW  - Survival Analysis
N1  - Publication Type: Journal Article; Multicenter Study
UR  - https://doi.org/10.1016/j.lungcan.2019.05.011
ER  -